文献速递儿童感染

新型检测法区分细菌与病毒感染的有效性验证

Validation of a Novel Assay to Distinguish Bacterial and Viral Infections.
PubMed 文献 · Pediatrics · 2017-09-13

在5个儿科急诊和2个病房开展双盲多中心检测评估,纳入361例疑似急性感染患儿,新型宿主蛋白联合检测区分细菌与病毒的灵敏度为93.8%、特异度89.8%,表现优于CRP和降钙素原。

要点

  • 新型检测区分细菌与病毒感染灵敏度93.8%、特异度89.8%。
  • 该检测准确性显著优于CRP和降钙素原。
  • 11.7%患儿检测结果为不确定。

核心结论

  • 双盲评估证实该新型检测在发热患儿中区分细菌与病毒感染具有高准确性。

研究设计与样本

  • 双盲、多中心检测评估,使用5个儿科急诊和2个病房的剩余血清,纳入≥3月龄至≤18岁无感染疑似(n=68)及疑似急性感染(n=529)患儿。

主要发现

  • 最终队列361例,参考标准诊断为病毒239例、细菌68例、不确定54例。
  • 检测区分细菌与病毒的灵敏度93.8%(95%CI 87.8%-99.8%),特异度89.8%(95%CI 85.6%-94.0%),11.7%结果不确定。
  • 检测优于CRP( cutoff 40 mg/L,灵敏度88.2%[80.4%-96.1%],特异度73.2%[67.6%-78.9%])和降钙素原( cutoff 0.5 ng/mL,灵敏度63.1%[51.0%-75.1%],特异度82.3%[77.1%-87.5%])。

关键数值与推荐

  • 感染队列纳入标准为发热≥38°C且症状持续时间≤7天。
  • 检测区分细菌与病毒灵敏度93.8%、特异度89.8%。

临床怎么用

  • 该检测可用于辅助区分儿童细菌与病毒感染,但需注意11.7%结果不确定。

局限性

  • 需额外研究支持其改善抗菌治疗决策的潜力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Reliably distinguishing bacterial from viral infections is often challenging, leading to antibiotic misuse. A novel assay that integrates measurements of blood-borne host-proteins (tumor necrosis factor-related apoptosis-inducing ligand, interferon γ-induced protein-10, and C-reactive protein [CRP]) was developed to assist in differentiation between bacterial and viral disease. METHODS: We performed double-blind, multicenter assay evaluation using serum remnants collected at 5 pediatric emergency departments and 2 wards from children ≥3 months to ≤18 years without (n = 68) and with (n = 529) suspicion of acute infection. Infectious cohort inclusion criteria were fever ≥38°C and symptom duration ≤7 days. The reference standard diagnosis was based on predetermined criteria plus adjudication by experts blinded to assay results. Assay performers were blinded to the reference standard. Assay cutoffs were predefined. RESULTS: Of 529 potentially eligible patients with suspected acute infection, 100 did not fulfill infectious inclusion criteria and 68 had insufficient serum. The resulting cohort included 361 patients, with 239 viral, 68 bacterial, and 54 indeterminate reference standard diagnoses. The assay distinguished between bacterial and viral patients with 93.8% sensitivity (95% confidence interval: 87.8%-99.8%) and 89.8% specificity (85.6%-94.0%); 11.7% had an equivocal assay outcome. The assay outperformed CRP (cutoff 40 mg/L; sensitivity 88.2% [80.4%-96.1%], specificity 73.2% [67.6%-78.9%]) and procalcitonin testing (cutoff 0.5 ng/mL; sensitivity 63.1% [51.0%-75.1%], specificity 82.3% [77.1%-87.5%]). CONCLUSIONS: Double-blinded evaluation confirmed high assay performance in febrile children. Assay was significantly more accurate than CRP, procalcitonin, and routine laboratory parameters. Additional studies are warranted to support its potential to improve antimicrobial treatment decisions.

来源:Pediatrics,查看原文。版权归原作者所有。

引用

  1. Srugo I, Klein A, Stein M, et al. Validation of a Novel Assay to Distinguish Bacterial and Viral Infections. Pediatrics. 2017. PMID: 28904072. doi:10.1542/peds.2016-3453

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。